62051
Federal Register / Vol. 69, No. 204 / Friday, October 22, 2004 / Notices
review and comment were published in
docket control number ATSDR174 and
toxicological profiles, comprising the
ATSDR171. This material is available
the Federal Register on October 23,
2nd set developed for the Department of
for public inspection at the Division of
2001, and August 7, 2001, with notice
Energy, prepared by ATSDR. The
Toxicology, Agency for Toxic
of a 90-day public comment period for
following toxicological profiles are now
Substances and Disease Registry, 1825
each profile, starting from the actual
available through the U.S. Department
Century Boulevard, Atlanta, Georgia,
release date. Following the close of the
of Commerce, National Technical
(not a mailing address) between 8 a.m.
comment period, chemical-specific
Information Service (NTIS), 5285 Port
and 4:30 p.m., Monday through Friday,
comments were addressed, and, where
Royal Road, Springfield, Virginia 22161,
except legal holidays.
appropriate, changes were incorporated
telephone 18005536847. There is a
into each profile. The public comments
charge for these profiles as determined
Availability
and other data submitted in response to
by NTIS.
This notice announces the availability
the Federal Register notices bear the
of one update and four new final
SECOND SET OF DOE PROFILES
Toxicological profile
NTIS order No.
CAS No.
1.
Americium ......................................................................................................................................................
PB2004104396
7440359
2.
Cesium ...........................................................................................................................................................
PB2004104397
7440462
3.
Cobalt (Update) .............................................................................................................................................
PB2004104398
7440484
4.
Iodine .............................................................................................................................................................
PB2004104399
7553562
5.
Strontium .......................................................................................................................................................
PB2004104400
7440359
Evaluate the changes in the
Georgi Jones,
the health and quality of life of
occurrence of selected adverse
Americans with disabilities.
Director, Office of Policy, Planning, and
Evaluation, National Center for
reproductive outcomes likely to be
This announcement is only for non-
Environmental Health/Agency for Toxic
prevented by folic acid (e.g., neural tube
research activities supported by CDC. If
Substances and Disease Registry.
defects, oral clefts, and certain heart
research is proposed, the application
[FR Doc. 0423617 Filed 102104; 8:45 am]
defects) in relation to folic acid policies
will not be reviewed. For the definition
that have been instituted in different
of research, please see the CDC web site
BILLING CODE 416370P
areas of the world, including the
at the following Internet address: http:/
Americas, Europe, the Middle East,
/www.cdc.gov/od/ads/opspoll1.htm
DEPARTMENT OF HEALTH AND
Asia, and Africa.
Activities: Awardee activities for this
Promote or develop tools and
HUMAN SERVICES
program are as follows:
Develop and/or maintain an
guidelines to assist the development of
Centers for Disease Control and
birth defects surveillance activities in
international birth defects database that
Prevention
both developed and developing
includes data from developed and
countries.
developing countries from different
areas of the world.
Surveillance, and Prevention of Birth
is substantially involved in the program
Promote and operate an
Defects
activities, above and beyond routine
international collaboration and data
grant monitoring.
Announcement Type: New.
clearinghouse among international
CDC Activities for this program are as
Funding Opportunity Number: RFA
partners and birth defect registries that
follows:
05006.
enables international collaborative birth
Assist, if requested, in designing,
defect surveillance, epidemiologic
Catalog of Federal Domestic
assessment, and capacity building.
Assistance Number: 93.283.
methodologies and approaches used for
Using such international partners
Application Deadline: December 21,
population-based birth defects
and the international birth defects
2004.
surveillance.
database, evaluate, compare and
Assist, if requested, in analyzing
I. Funding Opportunity Description
confirm patterns and trends of birth
surveillance data related to birth
Authority: This program is authorized
defects occurrences.
defects.
Obtain, compile, and publish birth
under sections 317(k)(2) of the Public
Assist, if requested, in providing
Health Service Act [42 U.S.C.
defect surveillance data from areas in
scientific consultation and assistance in
247b(k)(2)].
the developed and developing world to
the study of birth defects and in the
Purpose: The purpose of the program
assess the impact of birth defects.
approaches to study design,
In collaboration with international
is to promote international surveillance
methodology, and implementation in
and prevention of birth defects. This
partners, conduct secondary data
the conduct of secondary data analyses.
program addresses the ``Healthy People
analyses in order to evaluate potential
Assist, if requested, in the
2010'' focus area(s) of Maternal, Infant
birth defect risk factors and identify
definition and format of the birth defect
and Child Health.
areas in need of epidemiologic
surveillance reports.
assessments.
Measurable outcomes of the program
Assist, if requested in developing
Disseminate the birth defect
will be in alignment with one of the
tools and guidelines for birth defect
surveillance data to member programs,
following performance goal(s) for the
surveillance.
partners such as national and
National Center on Birth Defects and
II. Award Information
international organizations, the World
Developmental Disabilities (NCBDDD):
Type of Award: Cooperative
Health Organization, other health
(1) Prevent birth defects and
Agreement. CDC involvement in this
agencies, and other interested parties.
developmental disabilities (2) improve
VerDate jul<14>2003
15:11 Oct 21, 2004
Jkt 205001
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
E:\FR\FMOCN1.SGM
22OCN1